ansuvimab-zykl 400 MG Injection

RxCUI: 2472156
RxNorm name: ansuvimab-zykl 400 MG Injection
Display name: ansuvimab-zykl 400 MG Injection
Full name: ansuvimab-zykl 400 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761172	Ebanga	ansuvimab-zykl	351(a)	Rx	2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ebanga	ANSUVIMAB	Emergent BioDefense Operations Lansing LLC	de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5	2026-08-13	Warnings, Adverse reactions	Exact identifier rxcui: 2472156

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
9c008384-379d-48d3-b5a5-9809ed0f655c	ansuvimab-zykl 400 MG Injection [PSN] · ansuvimab-zykl 400 MG Injection [SCD]	2	5	These highlights do not include all the information needed to use EBANGA™ safely and effectively. See full prescribing information for EBANGA. EBANGA (ansuvimab-zykl) for injection, for intravenous use Initial U.S. Approval: 2020	20250210
de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5	ansuvimab-zykl 400 MG Injection [PSN] · ansuvimab-zykl 400 MG Injection [SCD]	2	2	These highlights do not include all the information needed to use EBANGA™ safely and effectively. See full prescribing information for EBANGA. EBANGA TM (ansuvimab-zykl) for injection, for intravenous use Initial U.S. Approval: 2020	20260220